All In Biotech

Drug Trial Radar · NCT07400952

Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus

Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus

Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Dec 23, 2025

Primary completion

Apr 2027

Study completion Apr 2027

Sponsor

Lead sponsor
Glaukos CorporationIndustry
Sponsor type
Industry
First posted
Feb 10, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multi-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solution in subjects with keratoconus.

Conditions

  • Keratoconus

Interventions

  • GLK-221 Ophthalmic SolutionDrug

    GLK-221 Ophthalmic Solution administered twice daily to both eyes

  • Placebo Ophthalmic SolutionDrug

    Placebo Ophthalmic Solution administered twice daily to both eyes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from baseline in maximum corneal curvatureTime frame: 16 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Glaukos Clinical Study Site

    Westerville, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.